News & Article
-
Bloom X³ News：Congratulations to Dr. Joe Bolen and Orna Therapeutics on the Acquisition by Eli Lilly
Bloom X³ Inc. extends its sincere congratulations to Dr. Joe Bolen, Advisor to Bloom X³ and Chief Executive Officer of Orna Therapeutics, and to the entire Orna team on the announced acquisition by Eli Lilly and Company. According to the... -
Meeting with Nobel Laureate Prof. Shinya Yamanaka
Bloom X³ Inc. (Founder & CEO: Hiromichi Kimura) recently met with Nobel Laureate Prof. Shinya Yamanaka at Gladstone Institutes (a UCSF-affiliated research institute) in California, USA. Prof. Yamanaka is Director Emeritus of the Cent... -
Invited Talk at ASDRP: “Research vs. Business—How to Navigate Career Inflection Points”
Our CEO (Hiro Kimura, Ph.D., R.Ph.) was invited to ASDRP’s Guest Speaker Series and delivered a lecture for high school students in the San Francisco Bay Area.*ASDRP (Aspiring Scholars Directed Research Program): a nonprofit, private res... -
Why Human Judgment Still Matters in AI Drug Discovery: Reproducibility, Credibility, and the Invisible Rules of Scientific Trust
Introduction: AI Is Not a Shortcut to Truth AI is transforming how we discover drugs. It accelerates structural predictions, target discovery, and literature mining. But as its use grows, so does a silent risk: misplaced trust in the cor... -
AI and Drug Discovery: Beyond the Buzzwords
0. Introduction: Why Talk About AI and Drug Discovery Now? The term “AI-driven drug discovery” has become ubiquitous.Across pharmaceutical companies, startups, investors, and the media, it is spoken as if the future has already arrived. ... -
Notice of Execution of a Joint Research Agreement with the National Center for Geriatrics and Gerontology (NCGG)
— Launching a collaboration to advance foundational research in cancer- and aging-related fields with a view toward future translation and societal implementation — Bloom X³ (the “Company”) announces that it has entered into a joint rese... -
Press Release: Hiro Kimura, Ph.D., R.Ph., Founder & CEO of Bloom X³ (formerly The Global Blooming), has been officially selected as an awardee of the “Tokyo Emerging VC Fund Accelerator ” co-hosted by the Japan External Trade Organization (JETRO, under the Ministry of Economy, Trade and Industry of Japan) and Coolwater Capital.
This prestigious international accelerator program supports the development of next-generation venture capital leaders from Japan and promotes the creation of globally connected VC funds. Dr. Kimura’s selection reflects his outstanding t... -
Our New Name — Bloom X³
From Seed to Bloom. Synergy to the third power —Bloom X³ Today we become Bloom X³.Our purpose is simple and firm: every Seed we touch must bloom. By multiplying R&D × Business × Investment, we create a unique arena where transformati... -
Pioneering the Future of Cancer and Regenerative Medicine—Bloom X³（Former The Global Blooming） Incubator Project Selected for JETRO Subsidy
The drug discovery incubator project in collaboration with leading domestic and international institutions, led and promoted by The Global Blooming Inc. (Headquarters: Tokyo, CEO: Hiromichi Kimura), has been selected for the JETRO Subsid... -
Invited to participate in a Japanese government-related seminar on UAE investment
12